By comparing clinical cohorts and populations from Singapore and the US, researchers will study infectious diseases, corneal disorders, liver transplant outcomes, diabetes and lung cancer to uncover ...

With a strong start to fiscal 2026, NetraMark is reiterating its previously stated guidance of achieving C$8–$10 million in booked contract backlog by mid-2026. This outlook is ...

Shape Memory Alloys (SMAs) have emerged as critical components in the field of robotics, offering compact and ...

The digital health revolution is accelerating at an unprecedented pace, transforming how we diagnose diseases, deliver care, and manage wellness. From AI-powere ...

Deepa Bhadana is a researcher in genetics, plant breeding, and biotechnology with expertise that spans field trials, molecular marker technologies, bioinformatics, and AI-driven agriculture.

NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming ...

For more than a century, scientists have argued over what really drives cancer, yet the pieces of the puzzle have rarely fit ...

Sweat patches may one day be the status quo for medical tests ranging from glucose monitoring to drug detection. In A Nutshell No more needles: Scientists can now detect diseases like diabetes, ...

AI technology has brought many changes to the healthcare industry. Learn about the possibilities and challenges it creates in ...

Researchers at Karolinska Institutet and KTH have developed a computational method that can reveal how cells change and ...

Scientists discovered that certain gene changes allow cells to function even when frataxin, the protein lost in Friedreich’s ...